Multimodal Deep Learning for Prediction of Progression-Free Survival in Patients with Neuroendocrine Tumors Undergoing 177Lu-based Peptide Receptor Radionuclide Therapy
机构 * Department of Artificial Intelligence, Fraunhofer Heinrich Hertz Institute(人工智能部门,弗劳恩霍夫海因里希·赫兹研究所) ; Department of Nuclear Medicine, Charité—Universitätsmedizin Berlin(核医学部门,柏林查理医院) ; Department of Hepatology and Gastroenterology, Charité—Universitätsmedizin Berlin(肝病与胃肠病学部门,柏林查理医院) ; Division of Interventional Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center(介入放射学部门,纪念斯隆-凯特琳癌症中心) ; Department of Endocrinology and Metabolism, Charité—Universitätsmedizin Berlin(内分泌与代谢学部门,柏林查理医院) ; Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf(胃肠病、肝病和传染病诊所,杜塞尔多夫大学医院,海因里希·海涅大学医学部) ; Department of Electrical Engineering and Computer Science, Technische Universität Berlin(电气工程与计算机科学部门,柏林技术大学) ; Berlin Institute of Health at Charité – Universitätsmedizin Berlin(柏林查理医院健康研究所)
专题命中 多模态Agent :multimodal(title,abstract)